University of Maryland School of Medicine logo
Emergency Medicine
All Departments
UMSOM Assistant
UMEM Educational Pearls
  • Home
  • Departments
  • Emergency Medicine
  • CME
  • UMEM Educational Pearls
  • CME
  • Courses and Conferences
  • Free Open Access Medical Education
  • UMEM Educational Pearls

Search

Title: Refractory Status Epilepticus

Category: Critical Care

Keywords: refractory status epilepticus, ketamine, propofol, siezure, midazolam (PubMed Search)

Posted: 8/30/2016 by Mike Winters, MBA, MD

Ketamine for RSE?

  • Up to 43% of patients with status epilepticus may progress to refractory status epilepticus (RSE).
  • Propofol, midazolam, and barbituates are often recommended for patients with RSE.
  • Importantly, all of these medications may be limited by hypotension and respiratory depression.
  • Ketamine is emerging as adjuvant therapy for patients with RSE.
  • The loading dose of ketamine ranges from 0.5 to 3 mg/kg, followed by a maintenance infusion of 0.3 to 4 mg/kg/h.

References

Legriel S, et al. What's new in refractory status epilepticus? Intensive Care Med 2016. [Epub ahead of print]


University of Maryland School of Medicine logo
  • Departments
  • Programs
  • Research Centers
  • Institutes
  • Graduate Education
  • CIBR Cores
  • Offices of the Dean
    • University of Maryland, Baltimore
    • University of Maryland Medical Center
    • Medical Alumni Association of the University of Maryland
    • Health Sciences and Human Services Library
University of Maryland School of Medicine
655 W. Baltimore Street
Baltimore, MD 21201
Contact Us

© University of Maryland School of Medicine

    • Webmaster
    • Web Accessibility
    • Site Index
    • UMB Hotline
    • Employment
    • Map